[go: up one dir, main page]

HK1108382A - Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level - Google Patents

Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level Download PDF

Info

Publication number
HK1108382A
HK1108382A HK08102503.8A HK08102503A HK1108382A HK 1108382 A HK1108382 A HK 1108382A HK 08102503 A HK08102503 A HK 08102503A HK 1108382 A HK1108382 A HK 1108382A
Authority
HK
Hong Kong
Prior art keywords
temozolomide
patient
treating cancer
dosing regimen
cancer based
Prior art date
Application number
HK08102503.8A
Other languages
Chinese (zh)
Inventor
Zong Chen
Winograd Benjamin
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of HK1108382A publication Critical patent/HK1108382A/en

Links

HK08102503.8A 2004-11-09 2005-11-07 Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level HK1108382A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/626,258 2004-11-09

Publications (1)

Publication Number Publication Date
HK1108382A true HK1108382A (en) 2008-05-09

Family

ID=

Similar Documents

Publication Publication Date Title
ZA200703716B (en) Improved dosing regimen of temozolomide for treating cancer based on the patient's MGMT level
IL206984A0 (en) Analoges of benzoquinone-containing ansamycins for the treatment of cancer
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
AP2006003525A0 (en) Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AU2003234597A8 (en) Drug therapy for celiac sprue
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
IL164896A0 (en) Immunoconjugates for the treatment of tumours
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
AP2004002997A0 (en) Heterocyclic compounds for use in the treatment ofdisorders of the urinary tract.
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
WO2005003154A8 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
AU2003254146A1 (en) Methods for the treatment of parkinson's disease
MXPA03006412A (en) Methods of administering epothilone analogs for the treatment of cancer.
AU2003223538A1 (en) Methods for the treatment of cancer
WO2005089294A3 (en) Synthesis of indenoisoquinoliniums and methods of use
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
HK1108382A (en) Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level
AU2004281077A1 (en) Methods and agents for the treatment of cancer
WO2005052191A8 (en) Compositions and methods for the diagnosis and treatment of tumor
GB0327493D0 (en) Treatment medicament
AU2003247094A1 (en) Enhancing the effect of radioimmunotherapy in the treatment of tumors